Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Taro Pharm Inds (TARO)

Taro Pharm Inds (TARO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,101,152
  • Shares Outstanding, K 38,538
  • Annual Sales, $ 669,890 K
  • Annual Income, $ 281,780 K
  • 60-Month Beta 0.48
  • Price/Sales 4.64
  • Price/Cash Flow 10.36
  • Price/Book 1.58

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 1.72
  • Number of Estimates 1
  • High Estimate 1.72
  • Low Estimate 1.72
  • Prior Year 1.60
  • Growth Rate Est. (year over year) +7.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.34 +0.71%
on 08/23/19
87.09 -10.56%
on 08/09/19
-5.47 (-6.56%)
since 07/23/19
3-Month
77.34 +0.71%
on 08/23/19
97.03 -19.73%
on 05/24/19
-16.76 (-17.71%)
since 05/23/19
52-Week
76.93 +1.25%
on 12/21/18
109.42 -28.82%
on 04/29/19
-30.95 (-28.44%)
since 08/23/18

Most Recent Stories

More News
Taro: Fiscal 1Q Earnings Snapshot

HAIFA BAY, Israel (AP) _ Taro Pharmaceutical Industries Ltd. (TARO) on Thursday reported fiscal first-quarter net income of $66.2 million.

TARO : 77.89 (-3.21%)
Taro Provides Results for Quarter Ended June 30, 2019

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter ended June 30, 2019.

TARO : 77.89 (-3.21%)
Taro to Announce First Quarter Results on August 8, 2019

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2019, after the close of market on Thursday August 8, 2019....

TARO : 77.89 (-3.21%)
Actinic Keratosis Market Key Player Analysis By - Valeant Pharmaceuticals International, Inc., Galderma SA, Promius Pharma

The report mainly studies the size, recent trends and development status of the Actinic Keratosis market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities),...

VRX.TO : 30.80 (-3.33%)
TARO : 77.89 (-3.21%)
PRGO : 46.34 (-2.99%)
Why Taro Pharmaceutical (TARO) Could Be Positioned for a Slump

Taro Pharmaceutical (TARO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

CPIX : 5.35 (-0.37%)
TARO : 77.89 (-3.21%)
Actinic Keratosis Market Appreciable Impact in Near Future 2015-2021

The report mainly studies the size, recent trends and development status of the Actinic Keratosis market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities),...

VRX.TO : 30.80 (-3.33%)
TARO : 77.89 (-3.21%)
PRGO : 46.34 (-2.99%)
Taro Pharmaceutical (TARO) Misses Q4 Earnings and Revenue Estimates

Taro (TARO) delivered earnings and revenue surprises of -32.74% and -5.26%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

TARO : 77.89 (-3.21%)
Taro: Fiscal 4Q Earnings Snapshot

HAIFA BAY, Israel (AP) _ Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported fiscal fourth-quarter earnings of $58.4 million.

TARO : 77.89 (-3.21%)
Taro to Announce Full Year Results on May 22, 2019

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2019, on Wednesday, May 22, 2019.

TARO : 77.89 (-3.21%)
Taro Pharmaceutical (TARO) Earnings Expected to Grow: Should You Buy?

Taro (TARO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TARO : 77.89 (-3.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade TARO with:

Business Summary

Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals...

See More

Key Turning Points

2nd Resistance Point 81.78
1st Resistance Point 79.83
Last Price 77.89
1st Support Level 76.64
2nd Support Level 75.40

See More

52-Week High 109.42
Fibonacci 61.8% 97.01
Fibonacci 50% 93.18
Fibonacci 38.2% 89.34
Last Price 77.89
52-Week Low 76.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar